Parkinson's disease study for people with PRKN or PINK1 gene changes
Part of Brain & nervous system clinical trials.
This study follows people with Parkinson's disease who have certain genetic changes (in PRKN or PINK1 genes) and healthy volunteers to learn more about how the disease progresses over time. It may help improve future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old
- You are willing to travel to the NIH Clinical Center for study visits
- You can understand and sign a consent form
- If you have Parkinson's, you have a clinical diagnosis and have either one or two changes in the PRKN or PINK1 genes (or you have no known genetic cause)
- If you do not have Parkinson's, you may join if you carry one or two PRKN or PINK1 gene changes (non-manifesting) or as a healthy volunteer
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares different ways of targeting treatment for Parkinson's disease symptoms. It is designed for people with mild to moderate Parkinson's who have had symptoms for at least 2 years and are generally stable on their current medications.
This study builds a genetics “registry” of people diagnosed with Parkinson’s disease who agree to genetic testing. Your information may help researchers understand why Parkinson’s happens and improve future treatments.
This trial studies genetic and biological samples from people with Parkinson's disease, their at-risk relatives, and healthy volunteers. It aims to find biomarkers that could help with earlier diagnosis and better treatments.
This study is building a large, detailed group of people—some with Parkinson’s and some at higher risk—to understand early changes over time. It uses brain imaging (DaTscan SPECT), sometimes spinal fluid tests (lumbar puncture), and genetic information to help researchers better measure disease and develop future treatments.
This study is looking to improve how Parkinson’s and related brain conditions are identified and treated sooner. You may be asked to share your health information and provide blood or other samples, and possibly have procedures like a spinal fluid test or a small skin sample.
This study follows people with Parkinson’s disease, certain Parkinson-like conditions, and some people at higher risk. It helps researchers learn how these illnesses start and progress, which may lead to better earlier detection and care.
Hear when a new PARKINSON DIS trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.